About
Contact & Profiles
Research Areas
- Tuberculosis Research and Epidemiology
- Antibiotic Resistance in Bacteria
- Cancer therapeutics and mechanisms
Indian Institute of Technology Roorkee
2021
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis calls for an immediate search novel treatment strategies. Recently, BlaC, the principal beta-lactamase Mycobacterium tuberculosis, was recognized as a potential therapeutic target. BlaC belongs to Ambler class A, which is generally susceptible inhibitors currently used in clinics: tazobactam, sulbactam, clavulanate. Alterations at Ser130 conserved SDN loop confer resistance mechanism-based (MBIs)...
10.3389/fmicb.2021.710291
article
EN
cc-by
Frontiers in Microbiology
2021-10-08
Coming Soon ...